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Imanishi  and  Makela  (1,  2)  first  reported  that  the  primary  anti-4-hydroxy-3- 
nitrophenyl acetyi (NP) ~ antibody has a  heteroclitic  fine specificity in most strains of 
mice  expressing  the  Igh-1 b  allotype,  with  anti-NP  antibodies  binding  chemical 
analogues such as 4-hydroxy-5-iodo-3-nitrophenyl acetyl  (NIP)  with  greater  affinity 
than  NP itself;  the idiotype, termed  NP  b, was found predominantly expressed  along 
with  lambda  light  chains.  Cramer et  al.  (3)  furthered  these observations,  describing 
the occurrence of the NP  b idiotype on both primary anti-NP antibodies  and on NP- 
specific  receptors  isolated  from  immune  T  cells  of mice  with  the  Igh-1 b  allotype. 
Weinberger et al.  (4-6) noted a  similar fine specificity pattern on functional subpop- 
ulations of T  cells, namely NP-specific delayed-type hypersensitivity  (DTH)  effector 
and NP-specific suppressor inducer T  cells, showing the sharing of idiotypic structures 
between  receptors on  functional  subpoputations  of NP-specific T  cells  and  anti-NP 
antibodies. 
In  a  previous  report,  we  described  the  expression  of  cross-reactive  cutaneous 
sensitivity  (CS)  responses  induced  by NP-O-succinimide  (NP-O-Su)  and  elicited  by 
NIP-O-succinimide  (NIP-O-Su)  in strains of mice possessing the Igh-1 b allotype, but 
not in strains bearing allotypes Igh-1 c or Igh-1  j (7).  The present  report extends these 
observations  by analyzing the  cross-reactivity of NP-O-Su-induced  CS  responses  in 
additional  inbred  strains  of mice.  Some  strains  of mice  that  failed  to demonstrate 
cross-reactive  NP-induced  DTH  responses  were  able  to  mount  cross-reactive  CS 
responses after NP-O-Su priming, despite the absence of NP  b idiotype in these strains. 
The present  report  also  presents  evidence  for the  existence  of at  least  two  T  cell 
subsets within the NP-specific CS effector cell population, at least in the AKR strain: 
one H-2I-restricted, the other H-2K/D-restricted;  each associated with a distinct  fine 
specificity pattern, presumably the manifestation of different receptors on these T  cell 
subpopulations. 
Materials  and Methods 
Mice.  All mice were either purchased from The Jackson Laboratory, Bar Harbor, Maine, 
or were bred in the animal facilities  at Harvard Medical School, Boston, Mass.  Mice were used 
* Supported by grants AI-14732 and AI-00152 from the National Institutes of tteahh and grant PCM- 
77-22422 from the National Science Foundation. 
I Abbreviations used in  this paper: BGG, bovine gamma  globulin; CS,  cutaneous  sensitivity; DMSO, 
dimethy[ sulfoxide; DTH, delayed-type hypersensitivity; NIP, 4-hydroxy-5-iodo-3-nitrophenyl  acetyl; NIP- 
O-Su, NIP-O-succinimide; NP, 4-hydroxy-3-nitrophenyl acetyl; NP-O-Su, NP-O-succinimide. 
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at 2-12 mo of age, and were maintained on laboratory chow and acidified, chlorinated water 
ad libitum. 
Antigens.  NP-O-Su and NIP-O-Su were purchased from Biosearch Co., San Rafael, Calif. 
Dimethysulfoxide (DMSO) was purchased from Fisher Scientific Co., Pittsburgh, Pa. 
lrnmunizationfor CS Responses.  Animals were shaved and primed subcutaneously with satu- 
rated solutions of NP-O-Su (7 g/100 ml) or NIP-O-Su (7 g/100 ml) in DMSO. A total of 0.1 
ml of antigen was divided equally between two sites on either ventral flank, followed by 0.1 ml 
of borate-buffered saline at pH 8.6. 
Elicitation of CS Responses.  6 d  after immunization or  1-2 h  after adoptive transfer,  mice 
were challenged for the CS response. Antigen solutions were prepared  1 min before challenge, 
as  follows:  15 pl  of NP-O-Su  (2 g/100 ml  DMSO)  or NIP-O-Su (1  g/100 ml  DMSO)  was 
added  to 300 ffl of phosphate-buffered  saline,  pH  7.2,  in  a  glass  tube.  These experimental 
conditions were chosen to minimize the nonspecific inflammatory response. 25 ffi of the antigen 
solution was injected into the left footpad. Footpad swelling was measured 24 h after challenge, 
using an engineer's micrometer (Schlesingers  for Tools Ltd., Brooklyn, N.  Y.).  Swelling was 
determined as the difference, in units of 10  -3 cm, between the left and right footpad thickness. 
Adoptive Transfer of CS Responses.  Mice were immunized as described above. 6 d after priming, 
the  animals  were  sacrificed,  inguinal  lymph  nodes  removed,  and  a  single  cell  suspension 
prepared  (using a fine mesh screen).  The cells were washed twice in Eagle's minimal essential 
medium.  Viable  cells  were counted using trypan  blue.  4.0  ×  107 viable cells  were  injected 
intravenously into untreated recipients. Control mice received lymphocytes from normal donors. 
The  recipients  and  control  mice were challenged  with  NP-O-Su  or NIP-O-Su  1-2  h  after 
transfer, as described above. 
Data Analysis.  Two-tailed Student's t tests  were used to perform statistical  analyses. Data 
are expressed as the mean incremental footpad swelling _  SE in units of 10  -3 cm. 
Results 
Genetic Control of the Fine Specificity of NP-O-Su-induced CS Responses.  To extend our 
knowledge of the  strain  distribution  of the  fine specificity  pattern  of CS  responses 
induced by NP-O-Su, fine specificity analyses were conducted in  10 inbred strains of 
mice. Using the reactive compounds NP-O-Su or NIP-O-Su as 7% solutions in DMSO, 
mice were primed  subcutaneously on either  ventral  flank.  Subsequently,  mice were 
challenged with a  0.1% solution of NP-O-Su or a  0.05% solution of NIP-O-Su in the 
left hind footpad on the sixth day after sensitization because this induction period has 
been  shown  to  result  in  peak  responses  (7).  The  results  of these  experiments  are 
summarized in Table I. All strains of mice tested responded to homologous challenges, 
that  is,  to NP-O-Su challenge  after  NP-O-Su  priming,  and  to NIP-O-Su challenge 
after  NIP-O-Su  priming.  Further,  all  except  the  DBA/2  and  C3H  strains  showed 
significant  levels of cross-reactivity to NIP-O-Su challenge  after  NP-O-Su  priming. 
Our previous studies demonstrated that genes in the Igh region controlled the ability 
to  mount  such  cross-reactive  CS  responses  (7).  The  present  results  imply  that,  in 
addition  to mice with  the  Igh-1 b allotype,  strains  bearing  allotypes  Igh-1 a,  -1 °,  -I  e, 
and -1 f may also be able to generate NIP-cross-reactivity in NP-induced CS responses. 
This is in contrast to DTH  responses induced by NP-bovine gamma globulin  (BGG), 
in which NIP cross-reactive responses were only elicited in strains bearing the Igh-1 b 
allotype,  but  not  in  strains  possessing  the  Igh-1  a,  Igh-1 c,  Igh-1  d,  Igh-1  e,  or  Igh-1  j 
allotypes (4, 8). 
Genetic Restrictions and Fine Specificity of the Ability to Adoptively Transfer NP-O-Su-induced 
CS  Responses.  In  contrast  to  NP-specific  DTH  responses,  where  donor-recipient 
homology at I-A is required for successful transfer of reactivity (7), it has already been 
reported (7)  that homology at either the H-2K, I, or D  regions is sufficient for transfer 1556  T  CELL  RECEPTORS  IN CUTANEOUS SENSITIVITY 
TABLE  I 
Genetics of Cross-Reactivity in NP-O-SU-induced CS Responses* 
H-2  Igh-1 
Strain  Haplo-  Allo-  Immunogen 
type  type 
Footpad swelling responses:l: 
NP-O-Su  NIP-O-Su 
BALB/c  d  a  NP-O-Su  28.3 ±  3.8 (3)  22.3 +  2.7 (4) 
NIP-O-Su  NT  27.2 zt: 1.8 (5) 
C57L  b  a  NP-O-Su  32.8 ±  3.7 (4)  33.8 zl: 1.1  (4) 
NIP-O-Su  NT  22.0 +  2.6 (4) 
C57BL/6  b  b  NP-O-Su  17.5 ±  1.5 (6)  22.2 +  3.5 (5) 
NIP-O-Su  NT  16.2 zlz 3.7 (5) 
DBA/2  d  c  NP-O-Su  28.8 +  2.8 (5)  0.7 + 0.7 (6) 
NIP-O-Su  NT  19.8 +  2.3 (6) 
AKR  k  d  NP-O-Su  16.5 +  1.3 (4)  23.8 +  2.2 (4) 
NIP-O-Su  NT  37.5 +  2.5 (4) 
A/J  a  e  NP-O-Su  24.0 +  2.2 (4)  16.3 ±  1.3 (4) 
NIP-O-Su  NT  16.0 :i: 3.1 (3) 
A.CA  f  e  NP-O-Su  26.8 -  4.6 (5)  13.8 +  3.3 (6) 
NIP-O-Su  NT  24.9 +  2.7 (5) 
A.SW  s  e  NP-O-Su  32.0 +  4.0 (3)  29.0 zlz 2.7 (5) 
CE/J  k  f  NP-O-Su  29.5 +  2.4 (4)  43.6 +  1.1  (5) 
NIP-O-Su  NT  39.7 +  0.3 (3) 
C3H  k  j  NP-O-Su  32.0 "4- 3.1 (5)  6.8 ±  1.9 (5) 
NIP-O-Su  NT  19.8 ± 0.5 (5) 
* See text for experimental protocols. 
~: Responses expressed as mean increment +  ! SEM in units of 10  -3 cm. The number of mice/group is in 
parentheses.  NT, not tested.  P <  0.005 compared with unprimed mice challenged with the same agent. 
Background swellings for mice receiving challenges  alone were:  8.8 +  0.8  (18) for NP-O-Su; 8.0 +  1.0 
(15) for NIP-O-Su. 
of NP-specific CS responses.  Those earlier experiments  used  donors  that  carried  the 
Igh-1 b  allotype,  and  in  all  cases  both  NP-  and  NIP-reactivity  were  transferred 
concomitantly  by  NP-O-Su  immune  lymph  node  cells.  To  confirm  and  extend  our 
earlier work,  in  the  present  study  we  first  transferred  NP-O-Su-primed  lymph  node 
cells from B 10.BR, a  strain which bears the H-2 k haplotype,  Igh-1 b allotype, Igh-Np b 
gene for NP  b idiotype, and exhibits cross-reactive CS responses.  As is evident in Table 
II, these cells were able to concomitantly  transfer  both  NP-  and  NIP-reactivity  into 
naive recipients compatible at either H-2I (i.e., TBR-3, which is homologous with the 
H-2 k haplotype  at  the  I-A and,  possibly,  the  I-B  and  I-J subregions)  or H-2D  (i.e., 
C3H.OH)  regions, but not into those without H-2 homology (B10.RIII).  Nonimmune 
B 10.BR cells were unable to transfer NP-speeific CS reactivity into any of the recipient 
strains. 
To  complement  these  findings,  a  similar  experiment  was  conducted  using  donor 
C3H  mice, which carry the H-2 k haplotype,  Igh-1 j allotype, and are unable to mount 
NIP-cross-reactive  CS  responses  after  NP  priming.  NP-O-Su-primed  C3H  lymph 
node  cells could  successfully  transfer  NP-reactivity  into  both  TBR-3  and  C3H.OH 
naive  recipients,  but  not  into  B10.RIII.  NIP-cross-reactivity  was  not  tested  in  these 
transfer  experiments  because  C3H  had  already  been  shown  to  lack  this  property 
(Table I). 
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TABLE  II 
Fine Specificity Analyses of Genetic Restrictions in the Ability to Adoptively  Transfer NP-O-Su-induced CS 
Responses in BIO.BR and C3H* 
Regions of 
Experi-  Donor cells  Recipient  H-2 com- 
ment  patibility 
Footpad swelling responses-t 
NP-O-Su  NI P-O-Su 
BI0.BR  TBR-3  I  28.3 ±  2.3§ (4)  25.2 ±  2.0§ (5) 
NP-O-Su  C3H.Ott  D  27.3 ±  2.4§ (4)  27.0 ::t: 1.1§ (4) 
Primed  BI0.RIII  None  15.5 ±  0.5  (2)  13.7 ±  2.6  (3) 
BI0.BR  TBR-3  I  13.2 ± 0.5  (2)  NT 
Nonimmune  C3H.OH  D  14.6 ±  1.8  (5)  NT 
BI0.RIII  None  13.8 ::1:1.2  (5)  NT 
No transfer  B10.RIII  14.4 +  1.4  (5)  16.0:1:0.9  (5) 
C3H  TBR-3  I  23.4 ±  1.0§ (5)  NT 
NP-O-Su  C3H.OH  D  25.8 +  1.5§ (5)  NT 
Primed  B10.RIII  None  9.3 ::lz 3.4  (4)  NT 
C3H  TBR-3  I  12.0 +  1.9  (5)  NT 
Nonimmune  C3H.OH  D  12.0 ~  1.1  (5)  NT 
B10.RIII  None  13.2 ±  1.6  (6)  NT 
No transfer  B10.RIII  15.0 ztz 1.1  (6)  NT 
* See text for experimental protocols. 
Responses expressed  as mean increment +  1 SEM in units of 10  -a cm. The number of mice/group is in 
parentheses.  NT, not tested. 
§ P <  0.005 compared with unprimed mice challenged with same agent. 
linkage patterns  observed  between CS and  DTH  responses,  we then  transferred  NP- 
O-Su-sensitized AKR  lymph node cells into various recipient strains. The AKR  strain 
also  carries  the  H-2  k  haplotype  and  bears  the  Igh-1 d  allotype;  it  lacks  the  Igh-1 b 
allotype and  NP  b idiotype, yet is able to give cross-reactive CS responses to NIP-O-Su 
challenge after NP-O-Su  priming.  Our  observations  are summarized  in Table  III.  It 
is apparent  that when there was complete H-2 homology between donor and recipient, 
4.0  x  10 7  NP-O-Su  immune  AKR  lymph  node  cells  effectively  transferred  CS 
responsiveness  to challenge  with  either  NP-O-Su  or NIP-O-Su.  Further,  when  there 
was  H-2  compatibility  at  H-2D  or  at  H-2K  +  I-A,  both  NP-O-Su  and  NIP-O-Su 
could  elicit CS  responses  after  transfer  of NP-immune  cells.  In  contrast,  when  these 
same  cells were  transferred  into  mice  which  were  incompatible  at  the  K,  I,  and  D 
regions of the H-2 complex, no immunity  was  transferred.  However, when  there was 
homology  at  the  H-2I  region  alone  (i.e., TBR-3  as  the  recipient)  we were unable  to 
elicit cross-reactive CS responses  to  NIP-O-Su  challenges,  although  homologous  NP- 
specific  CS  responses  were  clearly  observed.  Therefore,  in  the  AKR  strain,  the 
specificity  of cells  that  recognize  NP  in  association  with  H-2D  differs  from  that  of 
cells that  recognize NP  in association  with I  region products. 
Discussion 
It  was  long believed  that  the  T  cell-dependent  phenomena  of DTH  and  contact 
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TAaLE  III 
Fine Specificity Analyses of Genetic Restrictions in the Ability to Adoptively  Transfer NP-O-Su-induced CS 
Responses in AKR* 
Regions of H-2 
Donor cells  Recipient  compatibility 
Footpad swelling responsesZ~ 
NP-O-Su  NIP-O-Su 
AKR 
NP-O-Su 
Primed 
AKR 
Nonimmune 
AKR  K,I,S,D  20.6 ±  1.7§ (5)  23.8 ± 2.2§ (5) 
C3H.OL  S,D  20.2 :t= 1.0§ (10)  20.8 ±  1.7§ (9) 
C3H.OH  D  20.4 ± 2.2§ (5)  20.6 ± 0.7§ (5) 
4R  K,I-A  22.8 ±  1.0§ (5)  20.0 ± 2.5§ (4) 
TBR-3  I  23.1 ±  1.4§ (11)  5.6 ±  1.5  (8) 
BI0.S  None  9.5 ±  1.1  (6)  7.4 ± 2.3  (5) 
BI0.GD  None  6.6 ±  1.5  (5)  6.4 ±  1.8  (5) 
C3H.OL  S,D  6.0 ±  1.7  (6)  NT 
C3H.OH  D  NT  10.4 ±  1.8  (5) 
4R  K,I-A  5.0 + 2.4  (5)  NT 
TBR-3  I  8.4 ± 2.2  (5)  7.3+ 3.2  (4) 
BI0.S  None  5.5 ±  1.9  (6)  NT 
B10.GD  None  NT  9.3 ±  1.1  (4) 
* See text for experimental protocols. 
:~ Responses expressed as mean increment ±  1 SEM in units of 10  -a cm. The number of mice/group is in 
parentheses. NT, not tested. 
§ P <  0.005 compared  with unprimed mice challenged with same agent. Background swellings for mice 
receiving challenges alone are given in the legend to Table I. 
or by reactive haptens, respectively (9,  10). That  is, both reactions exhibit a  delayed- 
type kinetics of elicitation, are transferable by appropriately sensitized T  cells, and 
are characterized histologically by a  similar mononuclear  cell infiltrate (11).  It was 
subsequently  demonstrated  that  a  genetic  difference  also  existed  between  the  two 
reactions, namely,  in  that  contact  sensitivity to  epicutaneously applied  2,4-dinitro- 
fluorobenzene  (12)  or to  NP-O-Su  (7)  could be transferred  between  strains of mice 
sharing either H-2K, I, or D  regions of the murine major histocompatability complex 
in contrast  to  DTH  responses to protein antigens, where only I  region homology is 
sufficient for adoptive transfer of reactivity (4,  12,  13). However, there are reports of 
DTH  responses  that  do  not  follow  similar  genetics:  Zinkernagel  (14)  found  that 
transfer of DTH  responsiveness to lymphocytic choriomeningitis virus was  H-2K/D 
restricted;  more  recently, Weiner et  al.  (15)  noted  that  DTH  responses  to  reovirus 
were  restricted  by  H-2D  and  by  H-2K  or  I-A/B.  Thus,  it  appears  that  genetic 
restrictions are not distinguishing characteristics that separate CS and DTH responses. 
The  cellular mechanisms  directing these T  cell-dependent  responses  may  be  better 
understood  if we consider the genetic criteria of the effector population rather than 
the  method  of sensitization.  Thus,  the  H-2K/D-restricted  reactivity may  reflect  a 
CTL-like effector cell population with  antigen  recognized in  association with  K/D 
region products on the surface of the target cell, whereas I-region-restricted responses 
involve  macrophage  presentation  of  antigen  in  company  with  I-region  products. 
Support  for  this contention  has  been  obtained  from  preliminary experiments dem- 
onstrating that NP-specific footpad swelling could be elicited with NP conjugated to 
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with the recipient at H-2I, whereas NP coupled directly to syngeneic cells could only 
elicit responses in H-2K/D-restricted combinations  (16).  We now extend the list of 
the differences between I region-and K/D-restricted T  cell subpopulations by further 
genetic approaches: that is, by a demonstration of distinct fine specificity patterns of 
H-2D- vs. I region-restricted clones. 
It  was  originally  found by  Imanishi  and  Makela  (1)  that  the  primary  anti-NP 
antibody has a heteroclitic fine specificity in most strains of mice carrying the Igh-1 b 
allotype, with  anti-NP  antibodies  binding  chemical  analogues,  such  as  NIP,  with 
higher avidity than NP itself. The idiotype, called NP  b, was expressed predominantly 
along with lambda light chain. These experiments were extended by Cramer et al. 
(3)  who  described  the  presence  of  the  NP  b  idiotype  on  both  primary  anti-NP 
antibodies and on NP-specific receptors isolated from immune T  cells from strains of 
mice  expressing  the  Igh-1 b allotype.  More  recently, Weinberger  et  al.  (4-6)  have 
discovered a  similar fine specificity pattern on functional subpopulations of T  cells, 
namely NP-specific DTH effectors and NP-specific afferent suppressor T  cells, thus 
illustrating idiotypic sharing between receptors on NP-specific T  cells and  anti-NP 
antibodies. Only strains of mice bearing the Igh-1 b allotype demonstrated NIP-cross- 
reactive  DTH  responses  to  NIP-bovine  serum  albumin  challenge  after  NP-BGG 
priming. 
The strain  distribution  patterns of NIP-cross-reactive responses after NP-specific 
induction differ between DTH and CS responses. In addition to the strains of mice 
carrying  the  Igh-1 b  allotype,  strains  expressing  the  heavy  chain  linkage  groups 
associated with the Igh-1 a, -1 d, -1 e, and -1 f allotypes are also able to respond to NIP- 
O-Su challenge after NP-O-Su priming. Although this pattern of association is distinct 
from that  for DTH or antibody responses,  CS  reactivity is  nonetheless apparently 
linked to the Igh complex, based on the previously reported finding that  C3H.SW 
(Igh-1 j)  does not  mount  an observable NIP-cross-reactive response, whereas  its  Igh 
congenic strain  CWB  (Igh-1 b)  does  (7).  Further,  the  inability of NP-O-Su-primed 
C3H  (Igh-P)  to demonstrate NIP-cross-reactive responses (Table I) does not appear 
to be due to the failure of mice carrying the C3H background genes to recognize NP 
in association with H-2K/D region products. As is evident in Table II, C3H NP-O-Su 
primed cells can indeed manifest significant CS reactions to NP-O-Su challenge in 
recipients homologous at either H-2I or H-2D. 
It is possible that the broader strain distribution pattern of NIP-cross-reactivity in 
CS responses may be related to the triggering of lower affinity clones in non-Igh-1 b 
strains by a  high concentration of antigen on the presenting cell surface. Consistent 
with  this  postulate  are  the  reports  of Stashenko  (17)  and  Karjalainen  (18)  who 
observed predominantly heteroclitic antibodies in the early (up to day seven) anti-NP 
antibody response of strains with non-Igh-I b allotypes, including BALB/c, A/J, and 
AKR,  during this time-period of maximal  tissue antigen  concentrations.  However, 
this would not explain the absence of NIP-cross-reactive NP-induced CS responses in 
DBA/2 mice, nor would it easily account for the observed fine specificity of K/D- vs. 
I-restricted clones. 
The possibility that the lack of NIP-cross-reactivity in non-Igh-1 b, I region-restricted 
clones was the result of a specific suppressor cell is less likely in view of the observation 
that cyclophosphamide pretreatment of AKR mice before NP-O-Su priming did not 1560  T  CELL  RECEPTORS  IN CUTANEOUS  SENSITIVITY 
significantly  alter  the  fine  specificity of responsiveness  (M.  Sunday,  Unpublished 
data.). 
With these strain distribution  patterns in mind, we can now analyze the differing 
fine specificities of H-2D-restricted  vs.  I  region-restricted  clones  in  NP-induced  CS 
responses.  It  has  already  been  demonstrated  that  when  the  donor  strain  of NP- 
immune lymph node cells bears the Igh-1 b and NP  b idiotype and, therefore, manifests 
NIP-cross-reactive NP-induced DTH responses, both K, D-restricted, and I-restricted 
clones give NIP-O-Su-elicited cross-reactions (7).  This was confirmed in the present 
study using B10.BR (H-2  k, Igh-1  b) as the donor of NP-O-Su immune cells (Table II). 
It should  be noted that  this does not  necessarily imply that  the I-restricted and  D- 
restricted  clones  from  NP-O-Su  primed  B10.BR  bear  identical  idiotypic  receptors, 
but  only  that  both  clones  manifest  a  similar  fine  specificity  pattern  under  the 
conditions employed. Further experiments are required to determine if the H-2I and 
H-2D restricted CS cells from the B 10.BR strain share similar receptors. 
However, as can be seen in Table III, when cells from the AKR strain, which carries 
the  Igh-1  d  allotype  and  lacks  the  NP  b  idiotype,  are  transferred  into  I-A  region 
compatible  recipients,  an  NIP-cross-reactive  NP-induced  CS  response  cannot  be 
elicited. In contrast, the AKR H-2D-restricted clone manifests NIP-cross-reactive NP- 
induced CS responsiveness. In the case of transfer of AKR NP-immune cells into 4R, 
a donor-recipient combination with H-2 homology at H-2K +  I-A, the observed NIP- 
cross-reactivity may be attributed to the K-restricted cells because, as noted above, I- 
A  region  homology  is  not  sufficient  to  transfer  cross-reactive  CS  responses.  The 
differing  fine  specificities  of I-  vs.  K-  or  D-restricted  combinations  in  AKR  NP- 
induced CS responses supports the existence of two separate effector cell populations, 
or  clones,  in  CS  reactions.  Further,  these  results  are  consistent  with  the  concept 
originally suggested by Miller  (12)  and elaborated  by others  (7,  19,  20,  21)  that  at 
least  two  distinct  sets  of T  cells  may  be  capable  of mediating  the  inflammatory 
reaction  in  the  contact  sensitivity  response.  These  two  cell  populations  may bear 
distinct surface receptors, leading to their functional divergence: the first being DTH- 
like, I-restricted, and unable to give NIP-cross-reactive NP-induced responses in non- 
Igh-I  b strains  of mice;  the  second  being  CTL-iike,  K/D-restricted,  and  having  a 
different  pattern  or  NIP-cross-reactivity, consistent  with  the  observation  that  NP- 
specific  CTL  lack  the  NP  b  idiotype  (22-24).  Binz  et  al.  (25)  have  reported  the 
observation  that  different  spectra  of idiotypes  exist  on  two  subgroups  of T  cells 
generated  in  the same mixed  leukocyte culture,  namely, allo-Ia-binding Ly  1 +  2- 
blasts  and  H-2K/D-binding  Ly-2+  killer cells.  The evidence  in  the  present  study 
suggests that such a  dichotomy in idiotypic receptors between T  cell subpopulations 
may be a  generalized finding. 
The process by which  the ceil regulates which  Igh-V region genes are selected to 
recognize  the same antigen  in  association  with  distinct  H-2 region  products  is  not 
understood. However, at least two major possibilities could be considered: (a) different 
Igh-V region genes are selected to bind NP-modified H-2D and H-2I molecules.  (b) 
The same Igh-V region gene is selected but it can be modified by different self-H-2- 
recognition products to account  for the differential specificity of immune cells from 
AKR mice. 
Summary 
We have previously shown that cross-reactive cutaneous sensitivity (CS)  responses 
induced by 4-hydroxy-3-nitrophenyl acetyl-O-succinimide (NP-O-Su) and elicited by M.  E. SUNDAY, B.  BENACERRAF, AND M.  E.  DORF  1561 
its  5-iodo  analogue,  4-hydroxy-5-iodo-3-nitrophenyl  acetyl-O-succinimide  were  ob- 
served  in  strains  of mice possessing the  Igh-1 b allotype,  but  not  in  strains  bearing 
allotypes Igh-1  ~ or Igh-1  j.  These CS  responses are mediated  by T  cells and can be 
transferred to naive recipients that are homologous at either the H-2K, H-2I, or H-2D 
regions of the major histocompatibility complex. We now extend our analysis of cross- 
reactive 4-hydroxy-3-nitrophenyl-acetyl (NP)-induced CS responses to inbred strains 
of mice expressing additional Igh-1 allotypes. In contrast to NP-induced delayed-type 
hypersensitivity responses, which only display 4-hydroxy-5-iodo-3-nitrophenyl acetyl 
(NIP) cross-reactivity in Igh-1b-bearing mice, cross-reactive CS responses can also be 
elicited in NP-primed mice carrying the Igh-1 d, Igh-1  e, or Igh-1  f allotypes. Moreover, 
cross-reactive  NP-induced  CS  responses  could  be  transferred  by  NP-O-Su-primed 
lymph node cells from the AKR (Igh-1  d) strain, into naive recipients homologous at 
the H-2D region, but only non-cross-reactive NP responses could be transferred into 
strains homologous at the H-2I region. Furthermore, the lack of cross-reactivity in the 
Igh-l  J-bearing C3H strain was not the result of an inability of these mice to recognize 
NP in association with H-2K/D products, because NP-O-Su-primed cells from C3H 
donors  transferred  NP-specific CS responses into both H-2D and H-2I homologous 
recipients. The results are discussed with respect to the nature of the T  cell receptors 
that control NP responses. 
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